mefloquine is used to both prevent and treat certain forms of malaria mefloquine is useful for the prevention of malaria in all areas except for those where parasites may have resistance to multiple medications , and is one of several anti-malarial medications recommended by the united states centers for disease control and prevention for this purpose it is also recommended by the infectious disease society of america for malaria prophylaxis as a first or second-line agent , depending on resistance patterns in the malaria found in the geographic region visited it is typically taken for one to two weeks before entering an area with malaria if a person becomes ill with malaria despite prophylaxis with mefloquine , the use of halofantrine and quinine for treatment may be ineffective mefloquine is used as a treatment for chloroquine-sensitive or resistant plasmodium falciparum malaria , and is deemed a reasonable alternative for uncomplicated chloroquine-resistant plasmodium vivax malaria it is one of several drugs recommended by the united states ' centers for disease control and prevention it is not recommended for severe malaria infections , particularly infections from p common side effects include vomiting , diarrhea , headaches , and a rash severe side effects requiring hospitalization are rare , but include mental health problems such as depression , hallucinations , anxiety and neurological side effects such as ataxia , seizures , and tinnitus mefloquine is therefore not recommended in people with a history of psychiatric disorders or epilepsy available data suggests that mefloquine is safe and effective for use by pregnant women during all trimesters of pregnancy , and it is widely used for this indication compared to other malaria chemoprophylaxis regimens , however , mefloqinone may produce more side effects in non-pregnant travelers total clearance is through the liver , and the primary means of excretion is through the bile and feces , as opposed to only 4 % to 9 % excreted through the urine wrair transferred all its phase i and phase ii clinical trial data to hoffman-laroche and smith kline canadian soldiers who took mefloquine when deployed overseas have claimed they have been left with ongoing mental health problems 